Higher-valued flow generators, such as the S9 AutoSet (shown) and the S9 bilevels, contributed to a record quarter at sleep-disordered breathing solutions manufacturer ResMed. Revenue for the quarter ended September 30 was $357.7 million, a 5% increase (a 4% increase on a constant currency basis) over the quarter ended September 30, 2012. Net income was $80.9 million, an increase of 14% compared to the quarter ended September 30, 2012. Diluted earnings per share for the quarter ended September 30, 2013 were $0.56, a 14% increase compared to the quarter ended September 30, 2012. Mask spares and accessories did particularly well this quarter, says Mick Farrell, Chief Executive Officer, in a release.
“We continued to face a tough competitive product cycle this quarter. We have only just released our new mask products, but we were encouraged by their early sales. The Quattro Air is on its way to being one of the best mask launches ever,” Farrell says. “The Swift FX Nano, which was already selling well in Europe, was just launched in the U.S. in September with good reception. We have a rich pipeline of products scheduled for introduction over the course of this fiscal year, providing us with plenty of opportunities for robust growth ahead.”